Have a personal or library account? Click to login

Melolabial Advancement Flap for High-Risk BCC Near the Medial Eye Angle: Phototoxicity/ Photocarcinogenicity Triggered by Nitrosamines in the Polymedication as the Main Cause of Keratinocyte Cancer Development and Progression

Open Access
|May 2025

References

  1. Kim K, Park H, Lim KM. Phototoxicity: Its Mechanism and Animal Alternative Test Methods. Toxicol Res. 2015 Jun;31(2):97-104. doi: 10.5487/TR.2015.31.2.097. Erratum in: Toxicol Res. 2015 Sep;31(3):321. doi: 10.5487/TR.2015.31.2.097.
  2. Nishie K, Norred WP, Wasserman A, Keyl AC. Phototoxicity and differential hepatotoxicity as biological indicators of nitrosamine activity. Toxicol Appl Pharmacol. 1972 Dec;23(4):680-91. doi: 10.1016/0041-008x(72)90108-1.
  3. Schmidtsdorff S, Neumann J, Schmidt AH, Parr MK. Prevalence of nitrosamine contaminants in drug samples: Has the crisis been overcome? Arch Pharm (Weinheim). 2023 Feb;356(2):e2200484. doi: 10.1002/ardp.202200484.
  4. Robichová S, Slamenová D, Gábelová A, et al. An investigation of the genotoxic effects of N-nitrosomorpholine in mammalian cells. Chem Biol Interact. 2004 Jul 20;148(3):163-71. doi: 10.1016/j.cbi.2004.06.002.
  5. Mochizuki H, Nagazawa Y, Arimoto-Kobayashi S. Genotoxicity and the stability of N-nitrosomorpholine activity following UVA irradiation. Mutat Res Genet Toxicol Environ Mutagen. 2024 Jan;893:503721. doi: 10.1016/j.mrgentox.2023.503721.
  6. CDER Nitrosamine Impurity Acceptable Intake Limits [Internet]. U.S. Food and Drug Administration. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cder-nitrosamine-impurity-acceptable-intake-limits
  7. Tchernev G, Ivanov L. Mustarde rotation flap as adequate option for high-risk bcc near the lower eye lid: the additional intake of n-nitroso-folic-acid and n-nitroso-rivoroxaban as co- factors/triggers of the metabolic reprogramming of the future cancer cell. Georgian Med News. 2024 Jun;(351):131-137.
  8. Tchernev G. Nitrosogenesis lessons from dermatologists- nitrosamines/ndsris contamination of the polimedication in polimorbid patients as the most powerful skin cancer inductor: double hatchet flap for scc of the scalp occurring during treatment with valsartan/hydrochlorothiazide and lercanidipine. Georgian Med News. 2023 Sep;(342):74-79.
  9. Nitrosamine impurities in medicines [Internet]. Australian Government, Department of Health and Aged Care. Available at: https://www.tga.gov.au/how-we-regulate/monitoring-safety-and-shortages/industry-information-about-specific-safety-alerts-recalls-and-shortages/nitrosa-mine-impurities-medicines/appendix-1-established-acceptable-intake-nitrosamines-medicines
  10. Tchernev G. Nitrosogenesis of skin cancer: the nitrosamine contamination in the calcium channel blockers (amlodipine), beta blockers (bisoprolol), sartans (valsartan/losartan), ace inhibitors (perindopril/enalapril), tricyclic antidepressants (melitracen), ssris (paroxetine), snris (venlafaxine) and metformin: the most probable explanation for the rising skin cancer incidence. Georgian Med News. 2023 Jun;(339):24-32.
  11. Tchernev G. The nitrosamine contamination in beta blockers (bisoprolol/metoprolol), ace inhibitors (lisinopril/perindopril), thiazides diuretics (hct), calcium channel blockers (amlodipine/felodipine), sartans (candesartan) and the subsequent skin cancer development and progression: apocalypse now. Georgian Med News. 2023 Apr;(337):138-145.
  12. Tchernev G, Kordeva S, Lozev I. Metatypical bccs of the nose treated successfully via bilobed transposition flap: nitrosamines in aces (enalapril), arbs (losartan) as possible skin cancer key triggering factor. Georgian Med News. 2023 Feb;(335):22-25.
  13. Kuntz T, Grimm A, Hofmann SC, et al. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma. J Dtsch Dermatol Ges. 2024 Apr;22(4):513-519. doi: 10.1111/ddg.15379.
  14. Azoulay L, St-Jean A, Dahl M, et al. Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Hydrochlo-rothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study. J Am Acad Dermatol. 2023 Aug;89(2):243-253. doi: 10.1016/j.jaad.2023.04.035.
  15. Hou A, Li Y, Shadyab AH, et al. Photosensitizing antihypertensive medication and risk of skin cancer among postmenopausal women. J Dtsch Dermatol Ges. 2024 Feb;22(2):186-194. doi: 10.1111/ddg.15281.
  16. Tchernev G. (N-nitroso) propafenone induced advanced nodular melanoma-first reported case in the world literature: the inextricable links between the photocarcinogenesis, drug related nitrosogenesis and pharmaco-oncogenesis. Georgian Med News. 2024 Feb;(347):34-37.
  17. Tchernev G, Ivanov L, Broshtilova V. Multiple keratinocytic cancers after intake of antihypertensives (lisinopril/bisopro- lol/hct) and antiarrhytmics (propafenone): the important new links to the nitroso-contamination and the metabolic reprogramming of the future cancer cell. Georgian Med News. 2024 Jun;(351):65-71.
  18. Tchernev G. Nitrosamine contamination within cardiac multimedication – sartans (valsartan), calcium channel blockers (amlodipine and nifedipine), and antiarrhythmics (propafenone) as a significant factor in the development and progression of multiple keratinocytic cancers: advancement rotation flap for keratoacanthoma of the upper lip and undermining surgery for bcc of the shoulder as an optimal dermatosurgical approach. Georgian Med News. 2023 Sep;(342):152-155.
  19. N-Nitroso N-Desmethyl Rosuvastatin [Internet]. SynZeal. Available at: https://www.synzeal.com/en/n-nitroso-rosuvastatin-
  20. Tchernev G, Naydekova N. Melanoma and dysplastic nevi development after ranitidine/rilmenidine/moxonidine, lercanidipine, rosuvastatin and verapamil/trandolapril – new data/case series. The potential role of nitrosamine/ndsris contamination in polymedication as substantial skin cancer triggering factor. Georgian Med News. 2023 Nov;(344):152-158.
  21. Kordeva S, Ivanov L, Alexandrov A, et al. Keratinocyte cancers, dysplastic nevi and cutaneous melanoma development after intake of potentially nitrosamine/NDSRIs contaminated drugs: new data. Important links to photo-(nitroso-) carcinogenesis and pharmaco-oncogenesis. Medical Review (Med. pregled) 2024; 60(5): 62-72.
  22. Tchernev G, Dimova D. Education from dermatologists: the simultaneously development of 16 keratinocytic cancers after use of metformin in combination with losartan/hydrochlorothiazide, metoprolol and nifedipine- important links to drug related (photo)-nitroso-carcinogenesis and oncopharmacogenesis. Georgian Med News. 2024 Feb;(347):136-141.
  23. Tchernev G, Lozev I, Ivanov L. Morpheaform bcc of ala nasi: a successful dermatosurgical approach by transposition flap from the adjacent area. contamination of venlafaxine, bisoprolol and olanzapine with nitrosamines/ndsris: the most likely cause of skin cancer development and progression. Georgian Med News. 2023 Sep;(342):26-29.
  24. Tchernev G, Kordeva S. Nitrosogenesis of skin (human) cancer- the hidden truth of a neverending story: nitrosamine contamination in olmesartan, valsartan and hct as main risk factor for the development of keratinocyte cancer. Georgian Med News. 2023 Apr;(337):63-67.
  25. Woodard CR. Complications in facial flap surgery. Facial Plast Surg Clin North Am. 2013 Nov;21(4):599-604. doi: 10.1016/j. fsc.2013.07.009.
  26. Zoumalan RA, Murakami CS. Facial flap complications. Facial Plast Surg. 2012 Jun;28(3):347-53. doi: 10.1055/s-0032-1312702.
DOI: https://doi.org/10.2478/amb-2025-0029 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 76 - 80
Submitted on: Oct 21, 2024
Accepted on: Dec 6, 2024
Published on: May 15, 2025
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2025 G. Tchernev, S. Kordeva, A. Hristova, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.